Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Advanced Biomed Inc. ( (ADVB) ) has issued an announcement.
Advanced Biomed Inc. reported that on March 25, 2026, Steven I-Fang Cheng resigned from his roles as a member of the Board of Directors and as Chief Technology Officer, with the company specifying that his departure did not arise from any disagreement over its operations, policies, or practices. On the same day, the Board, acting on the Nominating Committee’s recommendation, appointed Chief Financial Officer Mingze Yin as a director, noting there are no family ties, special arrangements, or related-party transactions connected to his appointment, underscoring an effort to maintain transparent and compliant corporate governance.
More about Advanced Biomed Inc.
Advanced Biomed Inc. operates in the biomedical sector, focusing on technology-driven healthcare solutions and related innovations. The company’s leadership structure includes a Board of Directors and executive officers overseeing technology and financial functions, reflecting its emphasis on both product development and financial governance in the health technology market.
Average Trading Volume: 169,913
Technical Sentiment Signal: Strong Sell
Current Market Cap: $5.71M
For a thorough assessment of ADVB stock, go to TipRanks’ Stock Analysis page.